Thomas Glanzmann is Chairman of Grifols Inc. and Board Member of Grifols SA, a leading biopharmaceutical company headquartered in Barcelona, Spain. Before that, he held various positions in the healthcare and consumer industries. His main areas of expertise include management of global businesses, M&A and integration processes, and global strategic planning and business development.
As announced on February 23, 2012, Daniel Sauter has decided not to stand for reelection at the Annual General Meeting after serving for ten years.
More information on the upcoming Annual General Meeting: www.sulzer.com/AGM